Covishield, Covaxin to get full approval but won’t be retailing


The drug regulator’s subject expert committee (SEC) on Covid vaccines on Wednesday recommended full authorisation for the two widely used jabs — Covishield and Covaxin. However, the vaccines will continue to be available and administered only at the centres that are registered under the government’s CoWin platform, official sources said.